Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common stock, $0.0001 par value per share
-
Shares outstanding
-
75.9M
-
Number of holders
-
34
-
Total shares
-
6.32M
-
Shares change
-
+375K
-
Total reported value, excl. options
-
$155M
-
Value change
-
+$9.11M
-
Number of buys
-
22
-
Number of sells
-
-9
-
Price
-
$24.49
Significant Holders of CG Oncology, Inc. - Common stock, $0.0001 par value per share (CGON) as of Q1 2025
37 filings reported holding CGON - CG Oncology, Inc. - Common stock, $0.0001 par value per share as of Q1 2025.
CG Oncology, Inc. - Common stock, $0.0001 par value per share (CGON) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.32M shares
of 75.9M outstanding shares and own 8.34% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (4.36M shares), Pictet Asset Management Holding SA (748K shares), TimesSquare Capital Management, LLC (517K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (258K shares), Bank of New York Mellon Corp (148K shares), RHUMBLINE ADVISERS (74.7K shares), ALPS ADVISORS INC (56.4K shares), LOS ANGELES CAPITAL MANAGEMENT LLC (27.5K shares), Sicart Associates LLC (25K shares), and TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY (24.7K shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.